Ramy Abdelnaby: Exploring Advances in Antithrombotic Therapy for Noncardioembolic Ischemic Stroke
Ramy Abdelnaby, Consultant Neurologist / Oberarzt at RWTH Aachen University Hospital, shared on LinkedIn about a recent article by Brett Cucchiara et al, published in Stroke:
”Exploring advances in antithrombotic therapy for noncardioembolic ischemic stroke: The OCEANIC-STROKE trial marks a significant development with its dual-pathway inhibition approach using asundexian alongside antiplatelet therapy.
Current evidence highlights the efficacy of antiplatelet monotherapy and, in certain scenarios, the superiority of dual-antiplatelet therapy shortly after an event.
However, the emerging promise of factor XI/XIa inhibitors could revolutionize secondary stroke prevention, potentially enhancing efficacy without increasing bleeding risks.
Dive into the latest findings and what they signify for future treatment directions.”
Title: Antithrombotic Therapy for Noncardioembolic Ischemic Stroke: Current Evidence and Future Directions
Authors: Brett Cucchiara, Jean M. Connors, Alejandro A. Rabinstein, Mukul Sharma
Read the Full Article on Stroke
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 25, 2026, 18:36James P. Crowley: Gene Inactivation and Targeted Gene Repair as Two Approaches to CRISPR Gene Editing
-
Oct 25, 2026, 17:43Jan Sloves: Femoral Vein Aneurysm and Chronic Venous Obstruction
-
Oct 25, 2026, 17:31Kasimu Hussaini: Blood Component Therapy From Whole Blood to Targeted Treatment
-
Oct 25, 2026, 17:23Zahra Safarzadeh: When Low Factor VII Activity and Reduced VWF Antigen Coexist
-
Oct 25, 2026, 17:17Anubhav Joshi: Evans Syndrome in CLL A Differential Diagnosis to Remember
-
Oct 25, 2026, 17:04Tehila Alter: Tracking Hematopoietic Cell Engraftment in Bone Marrow Using CEST MRI
-
Oct 25, 2026, 16:45Shauna Riley։ First Guidelines for Hemoglobin SC Disease
-
Oct 25, 2026, 16:26Heghine Khachatryan: Patient Safety and Clinical Judgment in Platelet Transfusion Decisions
-
Oct 25, 2026, 16:13Funmi (Vanessa) Ullam: From Lived Experience to Research and Innovation in Sickle Cell Care